Vote For Cures
Nearly 50% of brand medicine spending goes to the supply chain and others
Let's Talk About Cost
New Resource Outlines Implications of Speaker Pelosi's Drug Pricing Plan
PhRMA Member Companies Raise Concerns With Impact Of Proposed International Pricing Index Model
The Pharmaceutical Research and Manufacturers of America, PhRMA, represents the country’s leading biopharmaceutical researchers and biotechnology companies.
latest from the
Blog
88%
decline in hiv/aids death rates
Since the 1990s
80%
of 340B volume goes through DSH hospitals even though they make up just 9% of 340B entities.
$2.6
billion
The average cost to develop one new medicine.
8
months
Priority FDA review time thanks to PDUFA
80+
autoimmune diseases
have been identified to-date
7,000
new medicines
Currently in development around the world.
